FOXO Technologies Inc. (FOXO)
- Previous Close
0.6361 - Open
2.0300 - Bid 0.9900 x 1000
- Ask 0.9920 x 1300
- Day's Range
1.3700 - 2.3800 - 52 Week Range
0.6150 - 13.0000 - Volume
197,414,228 - Avg. Volume
3,973,281 - Market Cap (intraday)
5.771M - Beta (5Y Monthly) 3.56
- PE Ratio (TTM)
-- - EPS (TTM)
-23.5400 - Earnings Date Jun 26, 2025 - Jun 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in Minneapolis, Minnesota.
foxotechnologies.com102
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: FOXO
View More
Performance Overview: FOXO
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FOXO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FOXO
View MoreValuation Measures
Market Cap
5.77M
Enterprise Value
19.96M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.58
Price/Book (mrq)
1.08
Enterprise Value/Revenue
4.93
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-17.42%
Return on Equity (ttm)
--
Revenue (ttm)
4.05M
Net Income Avi to Common (ttm)
-13.56M
Diluted EPS (ttm)
-23.5400
Balance Sheet and Cash Flow
Total Cash (mrq)
68.27k
Total Debt/Equity (mrq)
270.40%
Levered Free Cash Flow (ttm)
7.03M